MedTrace Logo

Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity

NCT00815126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2010-11-18

No results posted yet for this study

Summary

This study aims to compare the efficacy of nasal provocation test with Lysine-Acetylsalicylate in patients with history of NSAIDs hypersensitivity between mucocutaneous symptoms and respiratory symptoms and laboratory outcomes.

Conditions

  • Aspirin Hypersensitivity
  • NSAIDs Hypersensitivity

Interventions

PROCEDURE

Lysine-ASA Nasal ProvocationTest

Lysine-ASA 80 µl (16 mg of aspirin) will be installed in both nostrils with pipette

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Jettanong Klaewsongkram, MD · Chulalongkorn University

Study Design

Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-03-31
Completion
2009-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815126 on ClinicalTrials.gov